verified_user
Standardful
Homechevron_rightStandardschevron_rightGMP (cGMP)
ActiveInternational Standardupdate Standard Updated: Ongoingfact_check Fact checked: Jun 28, 2026

GMP (cGMP)

Good Manufacturing Practice — WHO Guidelines & FDA 21 CFR 210/211

apartmentPublishing Organization:World Health Organization (WHO) / U.S. Food and Drug Administration (FDA)

Standard Introduction

Good Manufacturing Practice (GMP, or cGMP for “current” GMP) is a system of guidelines ensuring that pharmaceutical products, food, biologicals, and medical devices are consistently produced and controlled according to quality standards. The World Health Organization first published GMP guidelines in 1969, and over 100 countries have incorporated WHO GMP provisions into their national laws. In the United States, the FDA enforces cGMP regulations under 21 CFR Parts 210 and 211.

GMP covers all aspects of production — from personnel qualification and facility design to raw material controls, process validation, quality control testing, and distribution. The principles require that manufacturers document and validate every step of production, maintain clean and controlled facilities, use qualified equipment, and keep thorough records. Regulatory agencies worldwide conduct inspections to verify compliance, and violations can result in warning letters, product recalls, facility shutdowns, and criminal prosecution.

science

Quality Assurance Framework

Ensures pharmaceutical and food products are consistently produced and controlled according to quality standards appropriate to their intended use.

public

Global Regulatory Foundation

Over 100 countries have incorporated WHO GMP provisions into their national medicines laws. The FDA enforces cGMP through 21 CFR Parts 210 and 211.

verified

Production & Control Standards

Covers personnel qualification, facility design, equipment validation, raw material controls, production processes, quality control testing, and documentation.

list_alt Core GMP Principles

  • Personnel qualification, training, and hygiene
  • Premises and equipment design and maintenance
  • Documentation and record keeping
  • Production process validation and control
  • Quality control and laboratory testing
  • Complaint handling and product recalls
  • Self-inspection and quality audits
  • Sanitation and contamination prevention

Who Needs to Comply?

groups

Manufacturers of pharmaceutical products, active pharmaceutical ingredients (APIs), biologicals, vaccines, medical devices, food products, and cosmetics. Required by virtually every national regulatory authority worldwide.

Key Requirements

1

Quality Management System

Establish a comprehensive quality management system covering production and quality control, with a designated quality unit independent of production responsible for release of finished products.

2

Process Validation

Validate manufacturing processes to demonstrate they consistently produce product meeting predetermined specifications and quality attributes. Maintain ongoing process verification.

3

Documentation & Records

Maintain complete batch production records, equipment logs, laboratory records, and standard operating procedures. All records must be contemporaneous, attributable, and indelible.

4

Facility & Equipment Controls

Design and maintain facilities and equipment to prevent contamination, mix-ups, and errors. Implement qualification protocols (IQ/OQ/PQ) for critical equipment.

5

Quality Control Testing

Operate adequately equipped laboratories with trained personnel to test raw materials, intermediates, and finished products against established specifications before release.

Implementation Roadmap

1
Phase 1schedule Duration: 2-4 weeks

Prepare scope, leadership and objectives

Define the good manufacturing practice quality system scope across facilities, equipment, materials, production, packaging, laboratory controls, records, and released products. Confirm leadership accountability, interested parties, legal and contractual obligations, policy commitments, and measurable objectives before detailed control work begins.

2
Phase 2schedule Duration: 4-8 weeks

Gap analysis and risk assessment

Assess current practices against GMP / cGMP requirements and the organization's risk context. Review quality unit oversight, validated processes, contamination control, batch records, deviations, CAPA, change control, and product release, then prioritize gaps by compliance exposure, customer impact, operational risk, and audit readiness.

3
Phase 3schedule Duration: 8-16 weeks

Implement processes, controls and records

Deploy or improve the required processes, operating controls, responsibilities, training, monitoring, documented information, and corrective-action workflows. Build evidence around SOPs, batch records, validation protocols, cleaning records, QC results, deviation investigations, CAPA records, and training records.

4
Phase 4schedule Duration: Ongoing

Audit, review and continually improve

Run internal audits, management reviews, performance monitoring, and corrective actions before the regulatory inspection or customer audit. Keep the system current after incidents, process changes, customer feedback, regulatory changes, or audit findings.

Compliance Checklist

0 / 12

checklist Scope and governance

checklist Operational controls and evidence

checklist Performance and improvement

Penalties & Enforcement

warning

FDA penalties include warning letters, product seizures, injunctions, facility shutdowns, consent decrees, and criminal prosecution. Adulterated drugs under 21 USC 331 can result in fines up to $500,000 and imprisonment up to 3 years. WHO prequalification loss bars products from UN procurement.

Frequently Asked Questions

Who needs GMP / cGMP?

expand_more

GMP / cGMP is relevant for organizations that need a disciplined good manufacturing practice quality system covering facilities, equipment, materials, production, packaging, laboratory controls, records, and released products. It is often adopted because customers, regulators, procurement teams, or market expectations require demonstrable controls and repeatable performance.

Is GMP / cGMP certifiable or auditable?

expand_more

Yes, organizations can normally pursue a regulatory inspection or customer audit against GMP / cGMP where certification or accreditation infrastructure exists. Even when certification is not the immediate goal, the standard can be used as an internal operating and assurance framework.

How long does implementation take?

expand_more

A focused implementation often takes several months, depending on scope, maturity, number of sites, process complexity, and evidence quality. Organizations with mature processes can move faster, while multi-site or regulated environments usually need more time.

What is the most important first step?

expand_more

Start with clear scope, leadership accountability, and an honest gap assessment. Without a stable scope and process ownership, teams usually create documents that do not match how work is actually performed.

What evidence do auditors expect?

expand_more

Auditors look for operating evidence, not just policy documents. Useful evidence includes SOPs, batch records, validation protocols, cleaning records, QC results, deviation investigations, CAPA records, and training records, plus proof that findings are reviewed and improved over time.

How often are internal audits needed?

expand_more

Internal audits should be performed at planned intervals based on risk, process importance, prior findings, and changes. Many organizations audit the full system annually and use targeted audits after incidents or major changes.

How does continual improvement work?

expand_more

Continual improvement uses performance data, audit findings, incidents, customer feedback, management review decisions, and corrective actions to strengthen the system. Improvement should be visible in objectives, controls, and measurable outcomes.

Can it be integrated with other standards?

expand_more

Yes. GMP / cGMP can usually be integrated with other management-system standards by sharing governance, document control, internal audit, corrective action, risk management, and management review processes.

Official Documentation

View All

Implementation Timeline

gavel
1962
US Congress mandates FDA to require GMP for drugs (Kefauver-Harris Amendment)
public
1969
WHO publishes first GMP guidelines as part of Certification Scheme
description
1978
FDA finalizes 21 CFR Parts 210 and 211 (cGMP for finished pharmaceuticals)
science
2000
ICH Q7 GMP guide for Active Pharmaceutical Ingredients published
update
2014
WHO TRS 986 Annex 2 updated GMP guidelines published
manage_search
Jan 2024
ICH Q9(R1) Quality Risk Management revision adopted by FDA, EMA and PMDA
new_releases
2025
FDA expands Quality Management Maturity (QMM) program for drug manufacturing sites
biotech
2026
EU GMP Annex 1 (Sterile Manufacturing) full enforcement after Aug 2024 grace period for lyophilizers

Related Categories